Until a vaccine is discovered and implemented for COVID-19, WDOM physicians on the frontlines continue to focus on diagnosis, drug treatment options, and best practice guidelines.
In response to the COVID-19 pandemic, faculty from across the Weill Department of Medicine have been pursuing critical research.
Funded by a $22 million grant from the National Institutes of Health and Three Lakes Partners, the PRECISIONS study aims to transform diagnosis and treatment for idiopathic pulmonary fibrosis.
A tribute to Dr. King’s legacy was held on October 2, 2019 at the Griffis Faculty Club as part of the division’s Briscoe-King Lung Club.
The treatment represents a major advancement in the management of individuals with COPD because it is the first minimally invasive procedure to help emphysema sufferers breathe better without major surgery.
Initiated in 2002, the award is given to fellows within the Weill Department of Medicine who have performed outstanding research. This year's finalists were presented at Medicine Grand Rounds on June 19.
The innate immune system is the body’s first line of defense against invading pathogens, but there has been a lack of information on what a “healthy” innate immune system looks like.
Dr. Weir's expertise includes treatment and symptom management for advanced lung disease, with an emphasis on compassionate care for the critically ill.
An expert in the pathophysiology of critical illness, including cardiopulmonary interface and advanced airway management, Dr. Manoach is known for his unwavering dedication to improving patient care.
Experts in intensive care will see patients in follow-up after an ICU admission. This practice will focus on ensuring ICU survivors have everything they need to allow their fullest recovery.